Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma
(Q37283401)
scientific article published on October 2008
scientific article published on October 2008
Language:
Current Data About
Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
2361-2366
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
21
|
||||||||||||||||
| (P478) |
33
|
||||||||||||||||
| (P577) |
Wednesday, October 1, 2008
|
||||||||||||||||
| (P921) |
(Q815547)
|
||||||||||||||||
| (P1433) |
(Q7577526)
|
||||||||||||||||
| (P1476) |
"Occipitocervical fusion using recombinant human bone morphogenetic protein-2: adverse effects due to tissue swelling and seroma" (language: en)
|
||||||||||||||||
| (P2093) |
Kiarash Shahlaie
Kee D Kim
|
||||||||||||||||
| (P13046) |
(Q7318358)
|
other details
| description | scientific article published on October 2008 |
External Links
| (P356) |
10.1097/BRS.0B013E318183971D
|
| (P698) |
18827703
|